Manufacturer record
Curetech Skincare: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
5 batches manufactured by Curetech Skincare (Himachal Pradesh) were declared Not of Standard Quality between October 2019 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
5 records linked to Curetech Skincare in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Betamethasone Valerate Ointment IP | RF695Mfg 2025-06 · Exp 2027-05 | Content of Betamethasone (73.7%)Other | Drugs Testing Laboratory, Chennai-06State lab | Jul 2026 |
| Betamethasone Valerate Ointment IP | RH896Mfg 2025-08 · Exp 2027-07 | ContentOther | DTL, Madurai-19State lab | Feb 2026 |
| Betamethasone Valerate Ointment IP | RF653Mfg 2025-06 · Exp 2027-05 | ContentOther | DTL, Chennai-06State lab | Feb 2026 |
| Apvaas 20 (Atorvastatin Calcium Tablets USP 20 mg) | RE641Mfg 2022-08 · Exp 2025-07 | Uniformity of weightUniformity of weight/content | CDTL MumbaiCDSCO lab | Jan 2023 |
| Betamethasone Dipropionate Cream IP | RD459Mfg 2019-04 · Exp 2021-03 | AssayAssay | RDTL ChandigarhState lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.